ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $212,649 | -47.1% | 10,702 | -54.4% | 0.02% | -38.9% |
| Q1 2023 | $402,332 | -26.7% | 23,487 | -31.7% | 0.04% | -16.3% |
| Q3 2022 | $549,000 | +123.2% | 34,397 | +92.0% | 0.04% | +115.0% |
| Q2 2022 | $246,000 | -27.4% | 17,914 | -16.1% | 0.02% | -28.6% |
| Q1 2022 | $339,000 | +15.7% | 21,347 | +59.0% | 0.03% | +7.7% |
| Q4 2021 | $293,000 | -25.6% | 13,426 | +2.0% | 0.03% | -44.7% |
| Q3 2021 | $394,000 | -16.3% | 13,167 | +23.7% | 0.05% | -34.7% |
| Q2 2021 | $471,000 | +21.4% | 10,645 | +21.9% | 0.07% | -15.3% |
| Q1 2021 | $388,000 | – | 8,736 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |